Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents

British Journal of Pharmacology

Volumn 125, Issue 3, 1998, Pages 549-555

  Wieland, H A ^a   Engel, W ^a   Eberlein, W ^a   Rudolf, K ^a   Doods, H N ^a  

^a BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

BIBO 3304; Food intake; NPY; Y1 receptor

Indexed keywords

APPETITE STIMULANT; GALANIN; N2 DIPHENYLACETYL N (4 UREIDOMETHYLBENZYL)ARGININAMIDE; NEUROPEPTIDE Y RECEPTOR; NEUROPEPTIDE Y RECEPTOR ANTAGONIST; NORADRENALIN; RECEPTOR SUBTYPE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SYNTHESIS; ENANTIOMER; FEEDING; FOOD INTAKE; HUMAN; HUMAN CELL; HYPERPHAGIA; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; THALAMUS MIDLINE NUCLEUS;

ANIMALS; ARGININE; CRICETINAE; CYCLIC AMP; EATING; HUMANS; HYPOTHALAMUS; KIDNEY; MALE; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; RATS; RECEPTORS, NEUROPEPTIDE Y; TUMOR CELLS, CULTURED;

EID: 0031660629     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702084     Document Type: Article

References (39)

1. AAKERLUND, L., GETHER, U., FUHLENDORFF, J., SCHWARTZ, T.H.W. & THASTRUP, O. (1990). Y1 receptors for neuropeptide Y are coupled to mobilization of intracellular calcium and inhibition of adenylate cyclase. FEBS Lett., 260, 73-78.
2. BALASUBRAMANIAM, A. (1997). Neuropeptide Y family of hormones: Receptor subtypes and antagonists. Peptides, 18, 445-457.
3. BARD, J.A., WALKER, M.W., BRANCHEK, T.A. & WEINSHANK, R.L. (1995). Cloning and functional expression of a human Y4 subtype receptor for pancreatic polypeptide, neuropeptide Y and peptide YY. J. Biol. Chem., 270, 26762-26765.
4. BING, C., WANG, Q., PICKAVANCE, L. & WILLIAMS, G. (1996). The central regulation of energy homoeostasis: roles of neuropeptide Y and other brain peptides. Biochem. Soc. Trans., 24, 559-565.
5. CLARK, J.T., KALRA, P.S., CROWLEY, W.R. & KALRA, S.P. (1984). Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats. Endocrinology, 260, 427-429.
6. CORP, E.S., MELVILLE, L.D., GREENBERG, D., GIBBS, J. & SMITH, G. (1990). Effect of fourth ventricular neuropeptide Y and peptide YY on ingestive and other behaviors. Am. J. Physiol., 259, R317-R323.
7. DANIELS, A.J., MATTHEWS, J.E., SLEPETIS, R.J., JANSEN, M., VIVEROS, O.H., TADEPALLI, A., HARRINGTON, W., HEYER, D., LANDAVAZO, A., LEBAN, J.J. & SPALTENSTEIN, A. (1995). High-affinity, neuropeptide Y receptor antagonist. Proc. Natl. Acad. Sci. U.S.A., 92, 9067-9071.
8. DOODS, H.N., WIELAND, H.A., ENGEL, W., EBERLEIN, W., WILLIM, K.-D., ENTZEROTH, M., WIENEN, W. & RUDOLF, K. (1996). BIBP3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties. Regulatory Peptides, 65, 71-77.
9. DOODS, H.N., WIENEN, W., ENTZEROTH, M., RUDOLF, K., EBERLEIN, W., ENGEL, W. & WIELAND, H.A. (1995). Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP3226. J. Pharmacol. Exp. Ther., 275, 136-142.
10. EDVINSSON, L., HAKANSON, R., WAHLESTEDT, C. & UDDMAN, R. (1987). Effects of neuropeptide Y on the cardiovascular system. Trends Pharmacol. Sci., 8, 231-235.
11. ENGEL, W., EBERLEIN, W., RUDOLF, K., DOODS, H.N., WIELAND, H.A., WILLIM, K.D., ENTZEROTH, M. & WIENEN, W. (1994). Amino acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them. BIBO 3304 Patent WO94/17035.
12. FUKURODA, T., IWAASA, H., KANATANI, A., TANAKA, T., ASANO, K., KITAGAWA, K., HIDAKA, M., MASHIKO, S., HISAKA, A., VAN DER PLOEG, L., MACNEIL, D., FUKAMI, T. & IHARA, M. (1997). Effect of a novel and orally bioavailable NPY Y5 receptor antagonist L-152,804 on feeding behaviour in rodents. Abstract at Seventh Annual Summer Neuropeptide Conference, Key West, Florida, June. 22-26.
13. GERALD, C., WALKER, M.W., CRISCIONE, L., GUSTAFSON, E.L., BATZLHARTMANN, C., SMITH, K.E., VAYSSE, P., DURKIN, M.M., LAZ, T.M., LINEMEYER, D.L., SCHAFFHAUSER, A.O., WHITEBREAD, S., HOFBAUER, K.G., TABER, R.I., BRANCHEK, T.A. & WEINSHANK, R.L. (1996). A receptor subtype involved in neuropeptide-Y-induced food intake. Nature, 382, 168-170.
14. GREGOR, P., MILLHAM, M.L., FENG, Y., DECARR, L.B., MCCALEB, M.L. & CORNFIELD, L.J. (1996). Cloning and characterization of a novel receptor to pancreatic polypeptide, a member of the neuropeptide Y receptor family. FEBS Lett., 381, 58-62.
15. HEDGE, G.S., BONHAUS, D.W., STANLEY, W., EGLEN, R.M., MOY, T.M., LOEB, M., SHETTY, S.G., DESOUZA, A. & KRSTENANSKY, U. (1995). Pharmacological evaluation of 1229U91, a novel high-affinity and selective neuropeptide Y Y1 receptor antagonist. J. Pharmacol. Exp. Ther., 275, 1261-1266.
16. HU, Y., BLOOMQUIST, B.T., CORNFIELD, L.J., DECARR, L.B., FLORES-RIVEROS, J.R., FRIEDMAN, L., JIANG, P., LEWIS-HIGGINS, L., SADLOWSKI, Y., SCHAEFER, J., VELAZQUEZ, N. & MCCALEB, M.L. (1996). Identification of a novel hypothalamic neuropeptide Y receptor associated with feeding behavior. J. Biol. Chem., 271, 26315-26319.
17. JACQUES, D., TONG, Y., DUMONT, Y.S., SHEN, H. & QUIRION, R. (1996). Expression of the neuropeptide Y Y1 receptor mRNA in the human brain: an in situ hybridization study. Neuroreport, 7, 1053-1056.
18. KALRA, S.P., DUBE, M.G., FOURNIER, A. & KALRA, P.S (1991). Structure-function analysis of stimulation of food-intake by neuropeptide Y: effects of receptor agonists. Physiol. Behav., 50, 5-9.
19. KANATANI, A., ISHIHARA, A., ASAHI, S., TANAKA, T., OZAKI, S. & IHARA, M. (1996). Potent neuropeptide Y Y1 receptor antagonist, 1229U91: Blockade of neuropeptide Y-induced and physiological food intake. Endocrinology, 137, 3177-3182.
20. KANATANI, A., ISHIHARA, A., KANNO, T., FUKURODA, T., HATA, M., ITO, J., VAN DER PLOEG, L., MAC NEAL, D., FUKAMI, T. & IHARA, M. (1997). Potent neuropeptide Y receptor antagonist 1229U91 inhibits NPY-induced and spontaneous food intake by the blockade of Y1 receptors but not Y5 receptors. Abstract at Seventh Annual Summer Neuropeptide Conference, Key West, Florida, June, 22-26.
21. KASK, A., RÄGO, L. & HARRO, J. (1996). Anxiogenic-like effect of the neuropeptide Y Y1 receptor antagonist BIBP3226: antagonism with diazepam. Eur. J. Pharmacol., 317, R3-R4.
22. LARSEN, P.J., TANG-CHRISTENSEN, M., SMITH, M.S. & CAMERON, J.L. (1997). Central administration of Neuropeptide Y potently stimulates food intake in male rhesus monkeys. Abstract 528.14, Neuroscience Meeting. Meeting of the Society for Neuroscience, Oct. 25-30.
23. LUNDBERG, J.M. & MODIN, A. (1995). Inhibition of sympathetic vasoconstriction in pigs in vivo by the neuropeptide Y-Y1 receptor antagonist BIBP3226. Brit. J. Pharmacol., 116, 2971-2982.
24. MATSUMOTO, M., NOMURA, T., MOMOSE, K., IKEDA, I., KONDOU, Y., AKIHO, H., TOGAMI, J., KIMUA, Y., OKADA, M. & YAMAGUCHI, M. (1996). Inactivation of a novel Neuropeptide Y / Peptide YY receptor gene in primate species. J. Biol. Chem., 271, 27217-27220.
25. MICHEL, M.C., BECK-SICKINGER, A., COX, H. DOODS, H.N., HERZOG, H., LARHAMMER, D., QUIRION, R., SCHWARTZ, T.H. & WESTFALL, T.H. (1998). XVI. International Union of Pharmacology Recommendations for the Nomenclature of Neuropeptide Y. Peptide YY, and Pancreatic Polypeptide Receptors. Pharmacol. Rev., 50, 143-150.
26. O'SHEA, D., MORGAN, D.G.A., MEERAN, K., EDWARDS, C.M.B., TURTON, M.D., CHOI, S.J., HEATH, M.M., GUNN, I., TAYLOR, G.M., HOWARD, J.K., BLOOM, C.I., SMALL, C.J., HADDO, O., MA, J.J., CALLINAN, W., SMITH, D.M., GHATEI, M.A. & BLOOM, S.R. (1997). Neuropeptide Y induced feeding in the rat is mediated by a novel receptor. Endocrinology, 138, 196-202.
27. PAXINOS, G. & WATSON, C. (1986). The rat brain in stereotaxic coordinates (2nd edn.), Academic Press Ltd: London UK.
28. ROSE, P.M., FERNANDES, P., LYNCH, J.S., FRAZIER, S.T., FISHER, S.M., KODUKULA, K., KIENZLE, B. & SEETHALA, R. (1995). Cloning and functional expression of a cDNA encoding a human type 2 neuropeptide Y receptor. J. Biol. Chem., 270, 22661-22664.
29. RUDOLF, K., EBERLEIN, W., ENGEL, W., WIELAND, H.A., WILLIM, K.D., ENTZEROTH, M., WIENEN, W., BECK-SICKINGER, A.G. & DOODS, H.N. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. Eur. J. Pharmacol., 271, R11-R13.
30. RUDOLF, K., EBERLEIN, W., ENGEL, W., BECK-SICKINGER, A.G., WITTNEBEN, H., WIELAND, H.A. & DOODS, H.N. (1997). BIBP3226, a potent and selective neuropeptide Y Y1-receptor antagonist. Structure-activity studies and localization of the human Y1 receptor binding site. In Neuropeptide Y and drug development. eds. Grundemar, L. & Bloom, S.R. pp. 175-190. Academic Press Ltd: London UK.
31. STANLEY, B.G., MAGDALIN, W., SEIRAFI, A., NGUYEN, M.M. & LEIBOWITZ, S.F. (1992). Evidence for neuropeptide Y mediation of eating produced by food deprivation and for a variant of the Y1 receptor mediating this peptide's effect. Peptides, 13, 581-587.
32. TOMASZUK, A., SIMPSON, C. & WILLIAMS, G. (1996). Neuropeptide Y, the hypothalamus and the regulation of energy homeostasis. Horm. Res., 46, 53-58.
33. TRINH, T., DUMONT, Y. & QUIRION, R. (1996). High levels of specific neuropeptide Y/pancreatic polypeptide receptors in the rat hypothalamus and brainstem. Eur. J. Pharmacol., 318, R1-R3.
34. WAHLESTEDT, C., PICH, M.P., KOOB, G.F., YEE, F. & HEILIG M. (1993). Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligonucleotides. Science, 259, 528-531.
35. WEINBERG, D.H., SIRINATHSINGHJI, D.J.S., TAN, C.P., SHIAO, L.-L., MORIN, N., RIGBY, M.R., HEAVENS, R.H., RAPOPORT, D.R., BAYNE, M.L., CASCIERI, M.A., STRADER, C.D., LINEMEYER, D.L. & MACNEIL, D.J. (1996). Cloning and expression of a novel neuropeptide Y receptor. J. Biol. Chem., 271, 16435-16438.
36. WIELAND, H.A., WILLIM, K. & DOODS, H.N. (1995a). Receptor binding profiles and NPY analogues and fragments in different tissues and cell lines. Peptides, 16, 1389-1394.
37. WIELAND, H.A., WILLIM, K.D., ENTZEROTH, M., WIENEN, W., RUDOLF, K., EBERLEIN, W., ENGEL, W. & DOODS, H.N. (1995b). Subtype selectivity and antagonistic profile of the nonpeptide Y1 receptor antagonist BIBP3226. J. Pharmacol. Exp. Ther., 275, 143-149.
38. WILDING, J.P.H. (1996). Metabolic actions of neuropeptide Y and their relevance to obesity. Biochem. Soc. Trans., 24, 576-581.
39. ZARJEVSKI, N., CUSIN, I., VETTOR, R., ROHNER-JEANRENAUD, F. & JEANRENAUD, B. (1993). Chronic intracerebroventricular neuropeptide Y administration to normal rats mimics hormonal and metabolic changes of obesity. Endocrinology, 133, 1753-1758.